SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-24-214253
Filing Date
2024-09-05
Accepted
2024-09-05 16:45:25
Documents
3
Group Members
REBA MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-C d831211dsctoc.htm SC TO-C 20630
2 EX-99.1 d831211dex991.htm EX-99.1 16962
3 GRAPHIC g831211g86z55.jpg GRAPHIC 7071
  Complete submission text file 0001193125-24-214253.txt   49091
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Subject) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-88023 | Film No.: 241281935
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 207 MOCKINGBIRD LANE JOHNSON CITY TN 37604
Business Address 207 MOCKINGBIRD LANE JOHNSON CITY TN 37604 423-926-4413
Crown Laboratories, Inc. (Filed by) CIK: 0002033289 (see all company filings)

IRS No.: 621840490 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C